Raymond James Financial Services Advisors
CRBP icon

Raymond James Financial Services Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

Raymond James Financial Services Advisors’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-551
Closed -$21K – 3195
2020
Q4 		$21K Sell
551
-8,581
-94% -$321K ﹤0.01% 2946
2020
Q3 		$493K Buy
9,132
+79
+0.9% +$14.3K ﹤0.01% 1973
2020
Q2 		$2.28M Sell
9,053
-2,163
-19% -$437K 0.01% 1057
2020
Q1 		$1.76M Buy
11,216
+1,071
+11% +$181K 0.01% 947
2019
Q4 		$1.66M Sell
10,145
-149
-1% -$22K 0.01% 1256
2019
Q3 		$1.5M Buy
10,294
+170
+2% +$29.6K 0.01% 1249
2019
Q2 		$2.1M Sell
10,124
-32
-0.3% -$6.85K 0.01% 1082
2019
Q1 		$2.12M Sell
10,156
-1,629
-14% -$359K 0.01% 1033
2018
Q4 		$2.06M Sell
11,785
-1,663
-12% -$332K 0.01% 883
2018
Q3 		$3.05M Sell
13,448
-820
-6% -$133K 0.01% 855
2018
Q2 		$2.16M Buy
14,268
+119
+0.8% +$21.6K 0.01% 975
2018
Q1 		$2.59M Sell
14,149
-352
-2% -$79.1K 0.01% 821
2017
Q4 		$3.09M Sell
14,501
-316
-2% -$67.6K 0.02% 726
2017
Q3 		$3.18M Buy
14,817
+608
+4% +$119K 0.02% 714
2017
Q2 		$2.69M Buy
14,209
+746
+6% +$146K 0.02% 751
2017
Q1 		$3.33M Buy
13,463
+704
+6% +$173K 0.03% 616
2016
Q4 		$3.23M Buy
12,759
+767
+6% +$176K 0.03% 583
2016
Q3 		$2.44M Buy
11,992
+3,167
+36% +$394K 0.02% 676
2016
Q2 		$792K Sell
8,825
-336
-4% -$26.3K 0.01% 1162
2016
Q1 		$497K Buy
9,161
+4,472
+95% +$197K 0.01% 1256
2015
Q4 		$232K Buy
+4,689
New +$239K ﹤0.01% 1495

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Raymond James Financial Services Advisors's CRBP Position: Q1 2021 in Review

Raymond James Financial Services Advisors sold out of Corbus Pharmaceuticals (CRBP) in Q1 2021, closing a stake of 551 shares — an estimated $21K sold.

Raymond James Financial Services Advisors first reported a position in CRBP in Q4 2015 and held it in 21 quarters. The position peaked at $3.33M in Q1 2017. 107 funds tracked by Wall St. Rank hold CRBP as of Q1 2021.

  • Raymond James Financial Services Advisors reported no remaining Corbus Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 551 Corbus Pharmaceuticals shares in Q1 2021, an estimated $21K.
  • Raymond James Financial Services Advisors first reported a position in Corbus Pharmaceuticals in Q4 2015 and held it in 21 quarters.
  • Raymond James Financial Services Advisors's Corbus Pharmaceuticals position peaked at $3.33M in Q1 2017.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q1 2021.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2021, filed 14 May 2021.